Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-853-9 | CAS number: 7761-88-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Health surveillance data
Administrative data
- Endpoint:
- health surveillance data
- Type of information:
- other: human data
- Adequacy of study:
- supporting study
- Reliability:
- other: not rated acc. to Klimisch
- Rationale for reliability incl. deficiencies:
- other: Well-documented health surveillance case study
Data source
Reference
- Reference Type:
- publication
- Title:
- A health surveillance case study on workers who manufacture silver nanomaterials
- Author:
- Lee, J.H et al.
- Year:
- 2 012
- Bibliographic source:
- Nanotoxicology 6(6), 667 - 669
Materials and methods
- Study type:
- biological exposure monitoring
- Endpoint addressed:
- repeated dose toxicity: inhalation
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- A health surveillance study was conducted in a workplace which manufactures silver nanomaterials, including the assessment of personal exposure levels to silver nanoparticles, a walk-through evaluation of the manufacturing process and the collection of blood and urine samples from two exposed workers who had worked for 7 years in the business of manufacturing silver nanomaterial.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Study on human exposure at workplaces where nanosilver is produced.
- IUPAC Name:
- Study on human exposure at workplaces where nanosilver is produced.
- Test material form:
- solid: nanoform
- Details on test material:
- - Name of test material (as cited in study report): silver nanoparticles (<100 nm)
Constituent 1
Method
- Type of population:
- occupational
- Ethical approval:
- not specified
- Details on study design:
SUBJECTS:
2 workers participated in the voluntary biomonitoring program. The workers were 37 and 42 years of age, male, and had worked for 7 years in the nanosilver manufacturing industry.
WORKPLACE DESCRIPTION:
A large-scale pilot reactor was used to manufacture silver nanoparticles <100 nm in size at a rate of 5 kg/day. Various types of precursor (wire type, powder type, liquid type) were fed through an inductively coupled plasma (ICP) torch, where the precursors were vaporised in the argon plasma. This vaporised precursor gas was then moved through a second zone of plasma produced from a passive ICP RF-antenna. In this zone, the atoms were condensed to nanoscale particles using a specific temperature gradient and cooling process. From the precursor feeding to the nanopowder collection, all the processes were conducted in a vacuum state. The connection from the reactor to the collector was a complete closed system, and thus very few silver nanoparticles were released from the collector into the workplace air. Silver nanoparticles ranging from 20 to 30 nm and manufactured as silver powders were introduced to the reactor using a torch and reacted with acetylene and oxygen gases. The manufactured silver nanoparticles were then amassed in a collector.
PERSONAL SAMPLING:
The air samples were taken by drawing air through mixed cellulose ester filters in sampling cassettes (37 mm diameter, 0.8 mm nominal pore-size, and 2 in. cowl) obtained from Pall Corp. (P/N 64678; Ann Arbor, MI). The filter samples for personal sampling were collected in the breathing zone using MSA (Escort Elf pump)-operated sampling pumps at a flow rate of 1.5–2.0 L/min and SKC (Leland Legacy pump)-operated sampling pumps at a flow rate of 6.9–7.3 L/min when the work duration was short. The sampling holders were also changed during the sampling period to avoid overload. The sampling with personal samplers was performed during the normal work period from 09:30 to 16:00 and typically lasted 159–350 min. The personal samplers were attached to the workers involved in the nanomaterial manufacturing. The total suspended particulate concentration was determined gravimetrically based on the NIOSH manual of analytical methods (NMAM) 0500 (1994)*.
SILVER ANALYSIS:
Silver concentrations on the filter were analysed using an ICP (Perkin Elmer optima 5300DV) based on the NMAM 7300-ICP method (NIOSH, 2003)* after wet digestion using the ICP-OES Plasma Spectrometer method. The filters were digested in a microwave (MARS Xpress, CEM) for 15 min at 150°C in the presence of nitric acid. After digestion, the samples were allowed to cool and analysed by ICP.
COLLECTION AND ANALYSIS OF BIOLOGICAL SAMPLES:
Urine and blood samples from 2 workers were collected after their shift. The analysis of the blood samples included the blood biochemistry and a haematological examination. The blood and urine were digested with concentrated nitric acid using the microwave digestion system (MARS 230/60, CEM). The concentration of silver in the digested fluid was then analysed by a flameless method using an atomic absorption spectrophotometer equipped with a Zeeman graphite furnace (Perkin Elmer 5100ZL, Zeeman Furnace Module, USA) based on the NIOSH 7300 method (2003)*.The concentration of silver in the tissue was expressed as µg/dl wet weight.
*References
- National Institute for Occupational Safety and Health (NIOSH), Manual of Analytical Methods (NMAM). 1994. Particulates not otherwise regulated, 0500. Cincinnati: NIOSH.
- National Institute for Occupational Safety and Health (NIOSH), Manual of Analytical Methods (NMAM). 2003. Elements by ICP 7300 (Nitric/Perchloric Acid Ashing). 4th ed. Cincinnati: NIOSH.
Results and discussion
- Results:
- Two male workers who had worked for 7 years in the business of manufacturing silver nanomaterial were exposed to silver concentrations of 0.35 and 1.35 mg/m3. The blood and urine levels of silver were 0.034 and 0.0135 mg/dl for blood and 0.043 mg/dl and not detected level for urine. The blood chemistry and haematology data were determined to be within a normal range. Taken together, the health surveillance indicated that the nanomaterial manufacturing workers were exposed to a much lower concentration of silver dust or soluble silver threshold limit values and showed no significant findings on their health status.
Any other information on results incl. tables
Table 1: Demographic data and silver concentrations related to personal exposure, and blood and urine samples
Worker | Gender/age | Occupational history (years) | TSP (mg/m3) | Air Ag (mg/m3) | Blood (µg/dL) | Urine (µg/dL) |
1 | Male/37 | 7 | 0.15755 | 0.00035 | 0.034 | 0.043 |
2 | Male/42 | 7 | 0.10869 | 0.00135 | 0.030 | ND |
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2